Successful use of Bruton's kinase inhibitor, ibrutinib, to control paraneoplastic pemphigus in a patient with paraneoplastic autoimmune multiorgan syndrome and chronic lymphocytic leukaemia
Andrew Lee; Suneet Sandhu; Louise Imlay‐Gillespie; Stephen Mulligan; Stephen Shumack
Author Information: Department of Dermatology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.